CVS Caremark To Pay $5 Million For Misrepresenting Prices Of Medicare Part D Drugs
Following a public comment period, the FTC has accepted as final an order with CVS Caremark settling charges that it misrepresented the prices of certain Medicare Part D prescription drugs, including drugs used to treat…